Drug intelligence / Profile preview

sambucus ebulus

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Topical
01

Overview

Sambucus ebulus is a perennial herbaceous plant known as dwarf elder, used extensively in traditional medicine across Europe and parts of Asia for its anti-inflammatory, antioxidant, anticancer, antimicrobial, analgesic, hepatoprotective, and immunomodulatory activities. Its pharmacological activity is attributed to high levels of flavonoids, anthocyanins, triterpenoids, tannins, saponins, and polyphenols. Extracts from different parts of the plant (flowers, leaves, roots, fruits) have been shown in preclinical studies to suppress inflammatory mediators like TNF-α, IL-1β, and IL-6, inhibit COX-2 (cyclooxygenase-2), and modulate immune and complement system activity. The fruit, rich in anthocyanins (notably cyanidin derivatives), exerts immune-modulatory effects, reduces inflammatory cytokines, and has demonstrated cytotoxicity in cancer models by inducing apoptosis. It has also shown antibacterial and antiviral activities against various pathogens in vitro. While much of its traditional and preclinical use is established, there are very limited clinical trials in humans to date, and further well-controlled studies are needed for regulatory approval and clinical integration[1][2][3][4].

Other names
dwarf elderdanewortEuropean dwarf elderelderberry (common name, not specific)ebulusebulum
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TLR4 (Toll-like receptor 4)C3

Beyond the preview

Go deeper on sambucus ebulus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sambucus ebulus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call